Matevž Arko

Dr. Matevž Arko

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KTKaja Troha
Kaja Troha
Domen VozelDomen Vozel
Domen Vozel
MAMatevž Arko
Matevž Arko
AZApolonija Bedina Zavec
Apolonija Bedina Zavec
DDDrago Dolinar
Drago Dolinar
Veronika Kralj-IglicVeronika Kralj-Iglic
Veronika Kralj-Iglic
The preparation of autologous platelet and extracellular vesicle-rich plasma (PVRP) has been explored in many medical fields with the aim to benefit from its healing potential. In parallel, efforts are being invested to understand the function and dynamics of PVRP that is complex in its composition and interactions. Some clinical evidence reveals beneficial effects of PVRP, while some report that there were no effects. To optimize the preparation methods, functions and mechanisms of PVRP, its constituents should be better understood. With the intention to promote further studies of autologous therapeutic PVRP, we performed a review on some topics regarding PVRP composition, harvesting, assessment and preservation, and also on clinical experience following PVRP application in humans and animals. Besides the acknowledged actions of platelets, leukocytes and different molecules, we focus on extracellular vesicles that were found abundant in PVRP.

12 December 2024 in Cells
Verified
Journal Article
Open access
PDF file
BKBoštjan Korenjak
Boštjan Korenjak
ATArmando Tratenšek
Armando Tratenšek
MAMatevž Arko
Matevž Arko
ARAnna Romolo
Anna Romolo
MHMatej Hočevar
Matej Hočevar
Veronika Kralj-IglicVeronika Kralj-Iglic
Veronika Kralj-Iglic
Extracellular nanoparticles (EPs) are a subject of increasing interest for their biological role as mediators in cell–cell communication; however, their harvesting and assessment from bodily fluids are challenging, as processing can significantly affect samples. With the aim of minimizing processing artifacts, we assessed the number density (n) and hydrodynamic diameter (Dh) of EPs directly in diluted plasma and blood using the following recently developed technique: interferometric light microscopy (ILM). We analyzed 613 blood and plasma samples from human patients with inflammatory bowel disease (IBD), collected in trisodium citrate and ethylenediaminetetraacetic acid (EDTA) anticoagulants, and 163 blood and plasma samples from canine patients with brachycephalic obstructive airway syndrome (BOAS). We found a highly statistically significant correlation between n in the plasma and n in the blood only in the human (i.e., but not canine) blood samples, between the samples with trisodium citrate and EDTA, and between the respective Dh for both species (all p < 10−3). In the human plasma, the average <Dh> was 139 ± 31 nm; in the human blood, <Dh> was 158 ± 11 nm; in the canine plasma, <Dh> was 155 ± 32 nm; and in the canine blood, <Dh> was 171 ± 33 nm. The differences within species were statistically significant (p < 10−2), with sufficient statistical power (P > 0.8). For <n>, we found no statistically significant differences between the human plasma and blood samples or between the samples with trisodium citrate and EDTA. Our results prove that measuring n and Dh of EPs in minimally processed fresh blood and in diluted fresh plasma by means of ILM is feasible for large populations of samples.